RETRACTED ARTICLE:Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation

Tumor Biology

Volumn 36, Issue 11, 2015, Pages 8511-8517

  Guo, Hui ^a   Xu, Yuemin ^a   Fu, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

CDKN1A; miR 208; Prostate cancer (PC)

Indexed keywords

CURCUMIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KI 67 ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 208; RNA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; MIRN208 MICRORNA, HUMAN; PROTEIN BINDING;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUNEL ASSAY; WESTERN BLOTTING; BIOSYNTHESIS; CARCINOMA; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CURCUMIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; PROSTATIC NEOPLASMS; PROTEIN BINDING;

EID: 84949090820     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3592-y     Document Type: TB

References (35)

1. Wong YN, Ferraldeschi R, Attard G, de Bono J. Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat Rev Clin Oncol. 2014;11:365–76.
2. Chang AJ, Autio KA, Roach 3rd M, Scher HI. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11:308–23.
3. Cetnar JP, Beer TM. Personalizing prostate cancer therapy: the way forward. Drug Discov Today. 2014;19:1483–7.
4. Lin R, Feng J, Dong S, Pan R, Zhuang H, Ding Z. Regulation of autophagy of prostate cancer cells by beta-catenin signaling. Cell Physiol Biochem. 2015;35:926–32.
5. Huang S, Liao Q, Li L, Xin D. Pttg1 inhibits smad3 in prostate cancer cells to promote their proliferation. Tumour Biol. 2014;35:6265–70.
6. Xia Q, Li C, Bian P, Wang J, Dong S. Targeting smad3 for inhibiting prostate cancer metastasis. Tumour Biol. 2014;35:8537–41.
7. Li T, Zhao X, Mo Z, Huang W, Yan H, Ling Z, et al. Formononetin promotes cell cycle arrest via downregulation of akt/cyclin d1/cdk4 in human prostate cancer cells. Cell Physiol Biochem. 2014;34:1351–8.
8. Gillies K, Wertman J, Charette N, Dupre DJ. Anterograde trafficking of cxcr4 and ccr2 receptors in a prostate cancer cell line. Cell Physiol Biochem. 2013;32:74–85.
9. Qian Y, Ma J, Guo X, Sun J, Yu Y, Cao B, et al. Curcumin enhances the radiosensitivity of u87 cells by inducing dusp-2 up-regulation. Cell Physiol Biochem. 2015;35:1381–93.
10. Fu XY, Zhang DW, Li YD, Zhao PW, Tang YQ, Niu JZ, et al. Curcumin treatment suppresses ccr7 expression and the differentiation and migration of human circulating fibrocytes. Cell Physiol Biochem. 2015;35:489–98.
11. Pu Y, Zhang H, Wang P, Zhao Y, Li Q, Wei X, et al. Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the ampk/uncoupling protein 2 pathway. Cell Physiol Biochem. 2013;32:1167–77.
12. Manju M, Vijayasree AS, Akbarsha MA, Oommen OV. Protective effect of dietary curcumin in anabas testudineus (bloch) with a special note on DNA fragmentation assay on hepatocytes and micronucleus assay on erythrocytes in vivo. Fish Physiol Biochem. 2013;39:1323–30.
13. Cort A, Timur M, Ozdemir E, Ozben T. Effects of curcumin on bleomycin-induced apoptosis in human malignant testicular germ cells. J Physiol Biochem. 2013;69:289–96.
14. Dorai T, Diouri J, O'Shea O, Doty SB. Curcumin inhibits prostate cancer bone metastasis by up-regulating bone morphogenic protein-7. J Cancer Ther. 2014;5:369–86.
15. Horie S. Chemoprevention of prostate cancer: soy isoflavones and curcumin. Korean J Urol. 2012;53:665–72.
16. Sundram V, Chauhan SC, Ebeling M, Jaggi M. Curcumin attenuates beta-catenin signaling in prostate cancer cells through activation of protein kinase d1. PLoS One. 2012;7, e35368.
17. Aggarwal BB. Prostate cancer and curcumin: add spice to your life. Cancer Biol Ther. 2008;7:1436–40.
18. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line pc-3. Oncogene. 2004;23:1599–607.
19. Wei X, Zhou D, Wang H, Ding N, Cui XX, Wang H, et al. Effects of pyridine analogs of curcumin on growth, apoptosis and nf-kappab activity in prostate cancer pc-3 cells. Anticancer Res. 2013;33:1343–50.
20. Wei X, Du ZY, Cui XX, Verano M, Mo RQ, Tang ZK, et al. Effects of cyclohexanone analogues of curcumin on growth, apoptosis and nf-kappab activity in pc-3 human prostate cancer cells. Oncol Lett. 2012;4:279–84.
21. Shankar S, Srivastava RK. Involvement of bcl-2 family members, phosphatidylinositol 3'-kinase/akt and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30:905–18.
22. Xiao X, Gaffar I, Guo P, Wiersch J, Fischbach S, Peirish L, et al. M2 macrophages promote beta-cell proliferation by up-regulation of smad7. Proc Natl Acad Sci U S A. 2014;111:E1211–20.
23. Wu X, Yang N, Zhou WH, Xu J, Chen JJ, Zheng FM, et al. Up-regulation of p21 inhibits trail-mediated extrinsic apoptosis, contributing resistance to saha in acute myeloid leukemia cells. Cell Physiol Biochem. 2014;34:506–18.
24. Stockl S, Gottl C, Grifka J, Grassel S. Sox9 modulates proliferation and expression of osteogenic markers of adipose-derived stem cells (asc). Cell Physiol Biochem. 2013;31:703–17.
25. Li LQ, Li XL, Wang L, Du WJ, Guo R, Liang HH, et al. Matrine inhibits breast cancer growth via mir-21/pten/akt pathway in mcf-7 cells. Cell Physiol Biochem. 2012;30:631–41.
26. Mihailidou C, Papazian I, Papavassiliou AG, Kiaris H. Chop-dependent regulation of p21/waf1 during er stress. Cell Physiol Biochem. 2010;25:761–6.
27. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits growth of non-small cell lung cancer in vitro and in vivo. Cell Signal. 2015;27:1208–13.
28. Ge Z, Zhang B, Bu X, Wang Y, Xiang L, Tan J. Molecular mechanism of activating protein-4 regulated growth of hepatocellular carcinoma. Tumour Biol. 2014;35:12441–7.
29. Wang W, Wu X, Tian Y. Crosstalk of ap4 and tgfbeta receptor signaling in nsclc. Tumour Biol. 2015;36:447–52.
30. Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P. Targeting mir-21 for the therapy of pancreatic cancer. Mol Ther. 2013;21:986–94.
31. Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, et al. Changes in mir-143 and mir-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas. 2012;41:1280–4.
32. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of mir-200 and mir-21 expression by curcumin or its analogue cdf. Cancer Res. 2010;70:3606–17.
33. Li H, Zheng D, Zhang B, Liu L, Ou J, Chen W, et al. Mir-208 promotes cell proliferation by repressing sox6 expression in human esophageal squamous cell carcinoma. J Transl Med. 2014;12:196.
34. Liu A, Shao C, Jin G, Liu R, Hao J, Song B, et al. Mir-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion. Cell Biochem Biophys. 2014;69:341–6.
35. Huang SQ, Liao QJ, Wang XW, Xin DQ, Chen SX, Wu QJ, et al. Rnai-mediated knockdown of pituitary tumor- transforming gene-1 (pttg1) suppresses the proliferation and invasive potential of pc3 human prostate cancer cells. Braz J Med Biol Res. 2012;45:995–1001.